{"id":968050,"date":"2026-05-28T08:21:58","date_gmt":"2026-05-28T12:21:58","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-to-participate-in-upcoming-scientific-and-investor-conferences\/"},"modified":"2026-05-28T08:21:58","modified_gmt":"2026-05-28T12:21:58","slug":"inovio-to-participate-in-upcoming-scientific-and-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-to-participate-in-upcoming-scientific-and-investor-conferences\/","title":{"rendered":"INOVIO to Participate in Upcoming Scientific and Investor Conferences"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\">PLYMOUTH MEETING, Pa.<\/span>, <span class=\"legendSpanClass\">May 28, 2026<\/span> \/PRNewswire\/ &#8212; INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer and infectious diseases, today announced that it will participate in the following scientific and investor conferences:<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/2310866\/INOVIO_v1_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/2310866\/INOVIO_v1_Logo.jpg\" title=\"(PRNewsfoto\/INOVIO Pharmaceuticals, Inc.)\" alt=\"(PRNewsfoto\/INOVIO Pharmaceuticals, Inc.)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>\n        <b>Jefferies Global Healthcare Conference <\/b>(New York) <br \/><b>Date: <\/b>Thursday, June 4 <br \/><b>Time: <\/b>8:45 AM ET <br \/><b>Format: <\/b>Fireside Chat <br \/><b>Webcast: <\/b><a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4698256-1&amp;h=3749003054&amp;u=https%3A%2F%2Fevent.summitcast.com%2Fview%2FNgCqua4VVQjq9ibVWHVWca%2FadRiTkvKf4AnDsZYyXatz8&amp;a=https%3A%2F%2Fevent.summitcast.com%2Fview%2FNgCqua4VVQjq9ibVWHVWca%2FadRiTkvKf4AnDsZYyXatz8\" target=\"_blank\" rel=\"nofollow\">https:\/\/event.summitcast.com\/view\/NgCqua4VVQjq9ibVWHVWca\/adRiTkvKf4AnDsZYyXatz8<\/a>\u00a0<\/p>\n<p>\n        <b>World Orphan Drug Congress <\/b>(Boston) <br \/><b>Poster Presentation<\/b>: <i>Rare Disease Protein Replacement Therapeutics: The Transformational Potential of Next-Gen DNA Medicine <\/i><b>Date: <\/b>Thursday, June 11 <br \/><b>Time<\/b>: 12:00 \u2013 12:10 PM ET<\/p>\n<p>A replay of the investor event will be available for 90 days at the link above. Members of INOVIO&#8217;s management team will also be conducting one-on-one meetings with investors during the investor conference.<\/p>\n<p>\n        <b>About INOVIO <br \/><\/b>INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO&#8217;s technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4698256-1&amp;h=4002293532&amp;u=https%3A%2F%2Fwww.inovio.com%2F&amp;a=www.inovio.com\" target=\"_blank\" rel=\"nofollow\">www.inovio.com<\/a>.<\/p>\n<p>\n        <b>Contacts <br \/><\/b>Media: Jennie Willson, (267) 429-8567, <a href=\"mailto:communications@inovio.com\" target=\"_blank\" rel=\"nofollow\">communications@inovio.com<\/a><br \/>Investors: Peter Vozzo, ICR Healthcare, (443) 213-0505,\u00a0<a href=\"mailto:investor.relations@inovio.com\" target=\"_blank\" rel=\"nofollow\">investor.relations@inovio.com<\/a><\/p>\n<p>\u00a0<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=PH69800&amp;sd=2026-05-28\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/inovio-to-participate-in-upcoming-scientific-and-investor-conferences-302784250.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/inovio-to-participate-in-upcoming-scientific-and-investor-conferences-302784250.html<\/a><\/p>\n<p>SOURCE INOVIO Pharmaceuticals, Inc.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=PH69800&amp;Transmission_Id=202605280805PR_NEWS_USPR_____PH69800&amp;DateId=20260528\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire PLYMOUTH MEETING, Pa., May 28, 2026 \/PRNewswire\/ &#8212; INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer and infectious diseases, today announced that it will participate in the following scientific and investor conferences: Jefferies Global Healthcare Conference (New York) Date: Thursday, June 4 Time: 8:45 AM ET Format: Fireside Chat Webcast: https:\/\/event.summitcast.com\/view\/NgCqua4VVQjq9ibVWHVWca\/adRiTkvKf4AnDsZYyXatz8\u00a0 World Orphan Drug Congress (Boston) Poster Presentation: Rare Disease Protein Replacement Therapeutics: The Transformational Potential of Next-Gen DNA Medicine Date: Thursday, June 11 Time: 12:00 \u2013 12:10 PM ET A replay of the investor event will be available for 90 days at the link above. Members of INOVIO&#8217;s management team will also &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-to-participate-in-upcoming-scientific-and-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;INOVIO to Participate in Upcoming Scientific and Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-968050","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>INOVIO to Participate in Upcoming Scientific and Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-to-participate-in-upcoming-scientific-and-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"INOVIO to Participate in Upcoming Scientific and Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire PLYMOUTH MEETING, Pa., May 28, 2026 \/PRNewswire\/ &#8212; INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer and infectious diseases, today announced that it will participate in the following scientific and investor conferences: Jefferies Global Healthcare Conference (New York) Date: Thursday, June 4 Time: 8:45 AM ET Format: Fireside Chat Webcast: https:\/\/event.summitcast.com\/view\/NgCqua4VVQjq9ibVWHVWca\/adRiTkvKf4AnDsZYyXatz8\u00a0 World Orphan Drug Congress (Boston) Poster Presentation: Rare Disease Protein Replacement Therapeutics: The Transformational Potential of Next-Gen DNA Medicine Date: Thursday, June 11 Time: 12:00 \u2013 12:10 PM ET A replay of the investor event will be available for 90 days at the link above. Members of INOVIO&#8217;s management team will also &hellip; Continue reading &quot;INOVIO to Participate in Upcoming Scientific and Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-to-participate-in-upcoming-scientific-and-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-28T12:21:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2310866\/INOVIO_v1_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inovio-to-participate-in-upcoming-scientific-and-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inovio-to-participate-in-upcoming-scientific-and-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"INOVIO to Participate in Upcoming Scientific and Investor Conferences\",\"datePublished\":\"2026-05-28T12:21:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inovio-to-participate-in-upcoming-scientific-and-investor-conferences\\\/\"},\"wordCount\":229,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inovio-to-participate-in-upcoming-scientific-and-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2310866\\\/INOVIO_v1_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inovio-to-participate-in-upcoming-scientific-and-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inovio-to-participate-in-upcoming-scientific-and-investor-conferences\\\/\",\"name\":\"INOVIO to Participate in Upcoming Scientific and Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inovio-to-participate-in-upcoming-scientific-and-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inovio-to-participate-in-upcoming-scientific-and-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2310866\\\/INOVIO_v1_Logo.jpg\",\"datePublished\":\"2026-05-28T12:21:58+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inovio-to-participate-in-upcoming-scientific-and-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inovio-to-participate-in-upcoming-scientific-and-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inovio-to-participate-in-upcoming-scientific-and-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2310866\\\/INOVIO_v1_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2310866\\\/INOVIO_v1_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inovio-to-participate-in-upcoming-scientific-and-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"INOVIO to Participate in Upcoming Scientific and Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"INOVIO to Participate in Upcoming Scientific and Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-to-participate-in-upcoming-scientific-and-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"INOVIO to Participate in Upcoming Scientific and Investor Conferences - Market Newsdesk","og_description":"PR Newswire PLYMOUTH MEETING, Pa., May 28, 2026 \/PRNewswire\/ &#8212; INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer and infectious diseases, today announced that it will participate in the following scientific and investor conferences: Jefferies Global Healthcare Conference (New York) Date: Thursday, June 4 Time: 8:45 AM ET Format: Fireside Chat Webcast: https:\/\/event.summitcast.com\/view\/NgCqua4VVQjq9ibVWHVWca\/adRiTkvKf4AnDsZYyXatz8\u00a0 World Orphan Drug Congress (Boston) Poster Presentation: Rare Disease Protein Replacement Therapeutics: The Transformational Potential of Next-Gen DNA Medicine Date: Thursday, June 11 Time: 12:00 \u2013 12:10 PM ET A replay of the investor event will be available for 90 days at the link above. Members of INOVIO&#8217;s management team will also &hellip; Continue reading \"INOVIO to Participate in Upcoming Scientific and Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-to-participate-in-upcoming-scientific-and-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-28T12:21:58+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2310866\/INOVIO_v1_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-to-participate-in-upcoming-scientific-and-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-to-participate-in-upcoming-scientific-and-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"INOVIO to Participate in Upcoming Scientific and Investor Conferences","datePublished":"2026-05-28T12:21:58+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-to-participate-in-upcoming-scientific-and-investor-conferences\/"},"wordCount":229,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-to-participate-in-upcoming-scientific-and-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2310866\/INOVIO_v1_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-to-participate-in-upcoming-scientific-and-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-to-participate-in-upcoming-scientific-and-investor-conferences\/","name":"INOVIO to Participate in Upcoming Scientific and Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-to-participate-in-upcoming-scientific-and-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-to-participate-in-upcoming-scientific-and-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2310866\/INOVIO_v1_Logo.jpg","datePublished":"2026-05-28T12:21:58+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-to-participate-in-upcoming-scientific-and-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/inovio-to-participate-in-upcoming-scientific-and-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-to-participate-in-upcoming-scientific-and-investor-conferences\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2310866\/INOVIO_v1_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2310866\/INOVIO_v1_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-to-participate-in-upcoming-scientific-and-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"INOVIO to Participate in Upcoming Scientific and Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/968050","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=968050"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/968050\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=968050"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=968050"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=968050"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}